Siga Technologies INC splits its revenue into 2 lines in its filings. The largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Product Sales And Supportive Services at $37.9 million, 92% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Jun 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
Q3 FY2024
Sep 30, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
54
|
41
|
6
|
4
|
3
|
81
|
7
|
81
|
10
|
| Product Sales And Supportive Services |
45
-74.4%
share 83.0%
|
38
-52.1%
share 92.4%
|
4
-39.2%
share 56.7%
|
2
-97.2%
share 58.3%
|
1
-90.1%
share 34.0%
|
79
share 97.5%
|
6
share 82.7%
|
80
share 98.0%
|
9
share 89.3%
|
| Research And Development |
9
+54.6%
share 17.0%
|
3
+57.0%
share 7.6%
|
3
+121.8%
share 43.3%
|
2
-3.3%
share 41.7%
|
2
+62.2%
share 66.0%
|
2
share 2.5%
|
1
share 17.3%
|
2
share 2.0%
|
1
share 10.7%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SIGA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Accelerated filer
- SEC CIK
- 1010086
- Former names
- SIGA PHARMACEUTICALS INC (until May 25, 2000)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.